Become A Featured Company

Leading Cannabis Brand Launches First-Ever Dissolvable, CBD-Infused Drink Tablets

Ryan Allway

May 22nd, 2019

News

DENVER, May 22, 2019 /CNW/ – Today, Dixie Brands (CSE: DIXI.U), (OTC: DXBRF), (Frankfurt: 0QV), one of the cannabis industry’s leading consumer packaged goods (CPG) companies, unveils a new product from its wholly owned subsidiary,  Aceso™ Hemp. A growing line of indication-specific, hemp-derived supplements that promote optimal health, Aceso is proud to introduce Fizz Tabs, the first-ever line of dissolvable hemp-infused tablets to enter the cannabidiol (CBD) category. The line expansion creates an on-the-go option for consumers and promotes a powerful addition to wellness regimens.

Aceso Fizz Tabs, the first-ever line of dissolvable, CBD-infused drink tablets, are offered in three specific formulations: Calm, Soothe and Wellness. (CNW Group/Dixie Brands, Inc.)
Aceso Fizz Tabs, the first-ever line of dissolvable, CBD-infused drink tablets, are offered in three specific formulations: Calm, Soothe and Wellness. (CNW Group/Dixie Brands, Inc.)

“Aceso has been a pioneer in the hemp industry for years, allowing us to perfect sophisticated formulas based on herbalism that set the precedent for broad spectrum hemp,” said Kurt Forstmann, Vice President of Corporate Business Development for Aceso. “Projections indicate that the CBD category is expected to be a 45 billion dollar ($45 billion) industry by 2024, and we’re confident that our new Fizz Tabs are part of the next-generation of CBD products that are going to continue to set the pace for the category.”

An evolution of Aceso’s popular indication specific formulas, Calm, Soothe and Wellness, Fizz Tabs dissolve quickly in a glass of water, adding effervescence and flavor, and can be taken on an as needed basis with the benefits lasting for 4-6 hours. Designed in compact form for easy accessibility and convenience, the tablets are available in multiple flavors that each feature 10 mg of broad spectrum hemp per serving. The Fizz Tab line features:

  • Calm Fizz Tabs™ combine the calming properties of lavender, grapefruit and passionflower extracts with broad spectrum hemp oil to help people de-stress or reduce anxiety.
  • Soothe Fizz Tabs™ mix turmeric and bromelain with broad spectrum hemp oil to help ease daily aches and pains and reduce soreness.
  • Wellness Fizz Tabs™ are a blend of vitamins, broad spectrum hemp oil and capsaicin to promote energy, wellness and mood stability.

With a majority of brands in the CBD space providing rudimentary offerings, Aceso takes pride in the craft of creating effective products that use innovative formulas and natural ingredients.  As one of the first entrants into the category, Aceso brings a deep understanding of the industry’s complex regulatory structure and expertise in the production of safe, effective and compliant products that can be sold across the United States.

“As part of the cannabis industry’s leading consumer packaged goods company, Aceso creates products that cater to consumers who are increasingly looking for natural alternatives in their wellness regimens with our three specific formulations: Calm, Soothe and Wellness, ” said Hilal Tabsh, Vice President of Marketing and Distribution at Aceso. “Together, Aceso and Dixie have spent nearly a decade combined, investing in scientific research and technology that has unlocked the powers of hemp to deliver over-gratifying results for our consumers, and we’re pleased to offer Fizz Tabs as a new and innovative extension of our ever-growing portfolio.”

Aceso’s Fizz Tabs are conveniently packaged individually in a box of 20, and are priced competitively at $22.00 per box. Calm and Soothe Fizz Tabs can be purchased now at www.acesohemp.com, and Aceso Wellness Fizz Tabs will be available in June 2019.

ABOUT ACESO HEMP

Aceso Hemp is the next generation in hemp, pairing plant science with food science. Offering a growing line of indication-specific, hemp-derived supplements for promoting optimal health, Aceso Hemp was one of the first entrants in the category and brings a deep understanding of the industry’s complex regulatory structure and expertise in the production of safe, effective and compliant products that can be sold across the United States. Aceso Hemp’s scientists have studied, tested and perfected phyto-nutrient ratios that unlock the powers of hemp, resulting in sophisticated formulas that are easy for the body to absorb and activate. To find out more about Aceso Hemp’s innovative products, visit www.acesohemp.com/.

ABOUT DIXIE BRANDS, INC

Dixie Brands Inc., through its licensed partners, has been formulating award-winning THC and CBD-infused products since 2009.  Currently operating in five U.S. states, the Company is expecting to double its manufacturing and distribution capabilities in 2019 in the U.S. as well as expand internationally, including Canada and Latin America. Dixie leads the global industry in the development, packaging design, product innovation and quality control for the commercial production of cannabis infused products. While the Company started with a single flagship product, the Dixie Elixir (a THC-infused soda), it is now one of the industry’s most recognized consumer brands, expanding to over 100 products across more than 15 different product categories representing the industry’s finest edibles, tinctures, topicals and connoisseur grade extractions, as well as world-class CBD-infused wellness products and pet dietary supplements. Dixie’s executive team has been instrumental in the formation of the marijuana industry for recreational and medicinal use, serving as founding members on several national regulatory and business-oriented industry organizations. To find out more about Dixie’s innovative products, or about how Dixie is building the future of cannabis, visit www.dixiebrands.com.

SOURCE Dixie Brands, Inc.

For further information: please contact: Dixie Brands, Inc., C.J. Chapman, General Counsel and Secretary, cchapman@dixiebrands.com/ 303-945-3963; Media Inquiries, Desiree Rosa, MULTIPLY, dixie@wearemultip.ly / 646-499-3306; Media (Canada): Crystal Quast, Vincic Advisors, crystal@vincicadvisors.com / 647-529-6364; Investor Inquiries, Jeff Codispodi, Vincic Advisors, jeff@vincicadvisors.com / 647-278-9376

Related Links

http://dixieelixirs.com

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading